Jennifer S. Walker Sells 42,654 Shares of Wright Medical Group NV (WMGI) Stock

Wright Medical Group NV (NASDAQ:WMGI) SVP Jennifer S. Walker sold 42,654 shares of the firm’s stock in a transaction that occurred on Tuesday, June 26th. The shares were sold at an average price of $26.03, for a total value of $1,110,283.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Wright Medical Group stock opened at $25.96 on Friday. Wright Medical Group NV has a one year low of $19.01 and a one year high of $29.89. The company has a market cap of $2.68 billion, a P/E ratio of -118.00 and a beta of 0.78. The company has a current ratio of 1.42, a quick ratio of 0.95 and a debt-to-equity ratio of 1.46.

Wright Medical Group (NASDAQ:WMGI) last announced its quarterly earnings data on Wednesday, May 9th. The medical device company reported ($0.01) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.06. The firm had revenue of $198.54 million for the quarter, compared to the consensus estimate of $193.69 million. Wright Medical Group had a negative return on equity of 2.58% and a negative net margin of 22.11%. The firm’s revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the business posted ($0.09) earnings per share. research analysts predict that Wright Medical Group NV will post -0.16 earnings per share for the current year.

Several equities analysts have recently weighed in on WMGI shares. ValuEngine upgraded Wright Medical Group from a “sell” rating to a “hold” rating in a research report on Tuesday, May 29th. Leerink Swann raised their target price on Wright Medical Group from $27.00 to $32.00 and gave the company an “outperform” rating in a research report on Thursday, June 21st. Oppenheimer set a $25.00 target price on Wright Medical Group and gave the company a “hold” rating in a research report on Thursday, May 10th. BidaskClub upgraded Wright Medical Group from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 4th. Finally, TheStreet upgraded Wright Medical Group from a “d+” rating to a “c-” rating in a research report on Wednesday, June 13th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $29.67.

Hedge funds have recently bought and sold shares of the business. Jane Street Group LLC acquired a new stake in Wright Medical Group during the first quarter worth $235,000. A.R.T. Advisors LLC acquired a new stake in Wright Medical Group during the first quarter worth $258,000. GSA Capital Partners LLP acquired a new stake in Wright Medical Group during the first quarter worth $270,000. Landscape Capital Management L.L.C. acquired a new stake in Wright Medical Group during the fourth quarter worth $376,000. Finally, Invictus RG acquired a new stake in Wright Medical Group during the fourth quarter worth $411,000.

About Wright Medical Group

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Insider Buying and Selling by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply